The antagonism between MCT-1 and p53 affects the tumorigenic outcomes
2010

How MCT-1 and p53 Interact in Cancer

publication Evidence: high

Author Information

Author(s): Kasiappan Ravi, Shih Hung-Ju, Wu Meng-Hsun, Choy ChikOn, Lin Tai-Du, Chen Linyi, Hsu Hsin-Ling

Primary Institution: National Health Research Institutes

Hypothesis

MCT-1 may counteract p53 through diverse mechanisms that determine tumorigenic outcomes.

Conclusion

MCT-1 oncogenicity can overcome p53 function, which persistently advances tumor development.

Supporting Evidence

  • MCT-1 has been identified as a novel target gene of p53 transcriptional regulation.
  • Functional p53 suppresses MCT-1 promoter activity and mRNA stability.
  • MCT-1 decreases p53 promoter function and mRNA stability.
  • MCT-1 promotes tumorigenicity in mice xenografts of p53-null and p53-positive lung cancer cells.
  • The reactivation of p53 cannot restrain the tumorigenic impacts of MCT-1.

Takeaway

MCT-1 is a protein that helps cancer grow, and it can make a cancer-fighting protein called p53 less effective.

Methodology

The study involved in vitro and in vivo experiments, including luciferase assays, ChIP assays, and analysis of mRNA stability.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1476-4598-9-311

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication